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   ABSTRACT 
 
Background: Decreased endometrial recepti-
vity is suspected to be one of the factors causing 
infertility in women with Polycystic Ovary Syn-
drome (PCOS). Endometrial abnormalities in PC-
OS due to impaired balance include estrogen, 
progesterone, growth factors, cytokines and cell 
attachment modulators including leptin. This 
study aims to determine the expression of leptin 
in the endometrium which is suspected to be 
more common in PCOS patients and related fac-
tors. 
Subjects and Method: A retrospective-case 
control study was conducted at Dr. Moewardi 
general hospital, Surakarta. A total of 60 women 
were involved; 30 infertile women with PCOS 
based on Rotterdam criteria (if found two of the 
three symptoms, including hyperandrogenism, 
ovulation dysfunction and/or polycystic ovaries 
from ultrasonography) and 30 normal women as 
control group. Demographic data such as age, 
family history of PCOS, menarche, BMI, occupa-
tion, and education were recorded. Leptin ex-
pression was acquired from endometrium biopsy 
with IHC examination on day 19-24 of menstrual 
cycle; under the condition that inclusion and ex-
clusion criteria are fulfilled. The statistical ana-
lysis was performed using Mann-Whitney test. 
Results: Mean of leptin expression was found 
significantly higher in PCOS group (Mean= 
59.16; SD= 49.34) compared to control group 
(Mean= 6.00; SD= 22.98, with p= 0.001. PCOS 
(b= 0.42; 95% CI= 0.10 to 0.73; p= 0.010) and 
obesity (b= 0.31; 95% CI= 0.41 to 0.58; p= 0.025) 
increased leptin expression. 
Conclusion: There is a difference in leptin ex-
pression in the endometrium of PCOS compared 
to normal. Leptin expression is higher in the en-
dometrium of women with PCOS and obesity 
compared to normal. 
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BACKGROUND 
The decrease of endometrial receptivity may 
contribute to low fertility rate in women with 
Polycystic Ovarian Syndrome (PCOS). PCOS 
displays hormonal imbalance that will dis-
rupt the mediator and modulator expression 
in endometrium, thus affecting endometrial 
receptivity and implantation process (Rarani 
et al, 2018). Several contributors to implant-
tation that may altered in PCOS include:  
1) estrogen, progesterone and its receptors; 
2) growth factor, Insulin-like Growth Factor-
1 (IGF-1), Vascular Endothelial Growth Fac-
tor (VEGF); 3) cytokines such as Leukemia 
Inhibitory Factor (LIF); MatrixMetalopro-
tein-9 (MMP-9); Interleukin-11; Colony 
Stimulating Factor-1 (CFS-1); Cyclooxygena
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se-2 (COX-2); and 4) modulator for cells 
attachments: Leptin, Integrin, Basigin (BSG) 
(Lessey and Young, 2019). 
The choice of endometrial receptivity 
markers is still a challenge due to the com-
plexity of its mediator and modulator expres-
sion. Therefore, further studies to understand 
the expression and its role to implantation in 
PCOS are required. 
In endometrium, LH and GnRH recep-
tors are expressed highest during luteal 
phase. The activation is accomplished 
through Adenylate cyclase and Phospholipase 
C signaling pathways and results in increased 
leptin concentration and its products (Dorn-
bush and Aeddula, 2018). Normally, leptin is 
expressed in endometrium during apposition 
in endometrial stroma. However, the expres-
sion is believed to increase in woman with 
PCOS, especially in those with obesity. This 
study aims to further understand the expres-
sion of leptin and its correlation with implan-
tation process in woman with PCOS. 
 
SUBJECTS AND METHOD 
1. Study Design 
This was a case-control study conducted at 
Dr. Moewardi general hospital, Surakarta. 
2. Population and Sample 
A total of 60 out-patient was selected by con-
secutive sampling and was classified into two 
groups. The case group consisted of 30 infer-
tile women with PCOS based on Rotterdam 
criteria. The control group consisted of 30 
women who underwent laparoscopy or lapa-
rotomy and were not diagnosed with PCOS; 
underwent sterilization, underwent a routine 
IVA test; underwent history taking and gyne-
cological examination and were not suspect-
ed of having PCOS (good fertility, no history 
of pelvic pain, no history of dysmenorrhea or 
dyspareunia, normal clinical gynecology exa-
mination). Women who were found to have a 
history or malignancy and refused as study 
subjects were not included in the study. 
3. Study Variables 
The dependent variable is leptin expression, 
Independent variables is PCOS woman with 
infertile and external variable age, family 
history of PCOS, menarche, body mass index 
(BMI), occupation, and education level. 
4. Operational Definition of Variables 
PCOS was heterogeneous abnormalities 
which characterized by two of the three 
symptoms from Roterdam criteria. 
Leptin expression is stained brownish 
color in luminal and glandular epithelial cells 
from coloring in Immunohistochemistry 
(IHC) through microscope. 
Age is the time of subject existence from the 
beginning of birth until this study conducted. 
Family history of PCOS was information 
of PCOS diseases in family members. 
Menarche was the first occurrence of 
menstruation. 
Body mass index (BMI) is a person’s 
weight in kilograms divided by the square of 
height in meters  
Occupation was the formal job or 
profession to earn income.  
Education level was the highest level of 
formal education achieved by the subject. 
5. Study Instruments 
The diagnosis of PCOS we gather from medi-
cal record. Leptin expression from endomet-
rium biopsy was carried out on day 19–24 of 
menstrual cycle using Pipelle Curette, 2-3 cm 
from the fundus area, followed by one micro-
curettage scraping. The sample was put into 
10% buffered formalin and was sent to ana-
tomical pathology department of Dr. Sardjito 
general hospital for immunohistochemistry 
(IHC) examination, using Rabbit Anti Leptin 
Polyclonal Antibody produced by BIOSS 
serial number bs-0409R which is specific for 
human antigens. While age, family history of 
PCOS, menarche, occupation, and education 
level are gather from quisionaire and body 
mass index (BMI) from measurment using 
scales. 
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6. Data Analysis 
Univariate analysis to describe the frequency 
distribution and percentage characteristics of 
the subjects. Bivariate analysis study to iden-
tified correlation between variables, in this 
study we use chi-square test and Mann-Whit-
ney test. Multivariate analysis using linear 
regression were performed using Statistical 
Product and Service Solution (SPSS) version 
22.0 software program. 
7. Research Ethics 
Research ethics included inform consent, 
anonymity, confidentiality and ethical clear-
ance. The eligibility in this study from Ethics 
Committee, Dr. Moewardi Regional Hospital. 
Ethic letter number 140/I/HREC/2020. 
 
RESULTS 
1. Univariate analysis 
The subjects of this study were 60 people; 
comprised of 30 infertile women with PCOS 
and the rest30 subject were normal condi-
tion. In univariate analysis, showing data of 
characteristics in both group. The PCOS 
group as a case and the normal group as a 
control. For Age category, the subjects were 
classified into two age groups: <36 years old 
and > 37 years old. This was based on the 
data that in women aged >37 years old, there 
is a decrease in egg quality and anti Mulle-
rian hormone. 
Table 1. Sample Characteristics 
Variable n  (%) 
Age <36 years old 40 66.6 
 >37 years old 20 33.3 
Employment unemployed 34 56.6 
 employed 26 43.3 
Education Primary school 24 40 
 
High school/ collage 36 60 
Family history of PCOS 
No 54 90 
Yes 6 10 
Menarche <13 years old 26 43.3 
 >14 years old 34 56.6 
BMI Normal 44 73.3 
 Obese 16 26.6 
 
Table 1 showed that age <36 years were 40 
women (66.6%) and ≥37 years were 20 
(33.3%). The subjects were also classified 
according to their education level; including 
9 years of primary school (elementary 
school/ junior high school); 3 years of high 
school or college graduate. Distribution at the 
level of education for the two groups is 
elementary/ junior high as many as 24 (40%) 
and high school/ graduate as many as 36 
(60%). There is a family history with PCOS of 
54 (90%) and no family history of PCOS of 6 
(10%). Menarche <13 years were 26 (43.3%) 
and menarche ≥14 years were 34 (56.6%). 
The normal BMI was 44 (73.3%) while the 
obese were 16 (26.6%). All demographics are 
further shown in Table 1. 
2. The result of bivariate analysis  
Chi-square was conducted to assess whether 
the variables are statistically equal in affect-
ing endometrial receptivity, as shown in Tab-
le 2. From the data obtained, mean of age in 
PCOS group was 32.30 years old, while in the 
control group was 35.80 years old. In <36 age 
group, 24 of them (60%) were included in 
PCOS group, while 16 of them (40%) were 
included in control group. In >37 age group, 
there were 6 (30%) women included in PCOS 
group and 14 (70%) women included in 
control group. 
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OR p PCOS Control 
n % n % n % 
Age <36 years old 24 60 16 40 40 100 0.28 0.028 
 ≥37 years old 6 30 14 70 20 100   
Employment unemployed 7 20.6 27 79.4 34 100 29.57 0.001 
employed 23 88.5 3 11.5 26 100   
Education 
Primary school 3 12.5 21 87.5 24 100 21.0 0.001 
High school/ collage 27 75 9 25 36 100   
Family history 
of PCOS 
No 26 48.1 28 51.9 54 100 2.15 0.671 
Yes 4 66.6 2 33.3 6 100   
Menarche <13 12 46.2 14 53.8 26 100 1.31 0.602 
 >14 18 52.9 16 47.1 34 100   
BMI Normal 17 38.6 27 61.4 44 100 6.88 0.040 
 Obesity 13 81.2 3 18.8 16 100   
 
The homogeneity between PCOS group and 
control group in terms of family history and 
menarche is not statistically significant (p= 
0.602). In contrast, there was a significant 
difference (p= 0.040) of BMI between the 
two groups. In PCOS group, 13 of them 
(81.2%) were obese and the rest have normal 
BMI; while in control group, 3 of them 




















Figure 1. Leptin Expression in endometrium from Immunohistochemistry 
examination of control group (A) 
A 
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Figure 2. Leptin Expression in endometrium from Immunohistochemistry 
examination of PCOS group (B) 
 
The difference of leptin expression 
among two control groups and its correlation 
with the occurrence of PCOS were assessed 
with bivariate analysis and correlation analy-
sis. For that matter, endometrial tissue of the 
two groups were observed with immuno-
histochemistry technique and visually ana-
lyzed using microscope magnification 40x10. 
The results are shown in Figure 1. 
In figure 1, the glandular cytoplasm and 
stroma are clear. While in figure 2, there is a 
brownish hue in glandular cytoplasm and 
stroma, indicative of increased leptin 
expression. Visually, it was clear that leptin 
expression on endometrial epithelia and 
glands during secretion phase were higher in 
PCOS group compared to control group.
Table 3. Differences in leptin expression in two groups 
Groups N Mean SD p 
Leptin with PCOS 30 59.16 49.34 0.001 
Leptin with Normal 30 6.0 22.98  
 
Bivariate analysis with Mann-Whitney test 
was conducted to compare leptin expression 
among the two groups. The result is shown 
on Table 3 showed the average leptin expres-
sion was higher in PCOS group (Mean= 
59.16; SD= 49.34) compared to control group 
(Mean= 6.0; SD= 22.98), with p= 0.001. 
3. The result of multivariate analysis  
Multivariate analysis was conducted to see 
correlation between variables with linear reg-
ression. The result is shown in Tables 4 and 
5. Table 4 shows a statistically significant 
effect between PCOS with leptin expression. 
PCOS affects the increase in leptin expression 
as much as 0.53 units (b= 0.53; 95% CI= 0.32 
- 0.73; p= 0.001). Likewise, Table 5 shows 
the influence of PCOS on Leptin expression 
after considering all existing external vari-
ables. Statistically significant influence was 
obtained. SOPK gives an effect of increasing 
as much as 0.42 units of leptin expression 
(b= 0.42; 95% CI= 0.10 - 0.73; p= 0.01). Obe-
sity also has effect of increasing as much as 
0.31 units on leptin expression (b= 0.31; 95% 
CI=0.41 - 0.58; p= 0.025) and it was statisti-
cally significant. 
B 
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Table 4. Leptin expression to PCOS  




95% CI p 
PCOS 0.53 0.56 0.32 – 0.73 0.001 
 
Table 5. Leptin expression to PCOS and external variable 




95% CI p 
PCOS 0.42 0.45 0.10 – 0.73 0.010 
Age < 0.01 < 0.01 -0.22 – 0.23 0.973 
Employment < 0.01 < 0.01 -0.28 – 0.30 0.962 
Education <-0.01 <-0.01 -0.28 – 0.27 0.970 
Family history of PCOS 0.14 0.09 -0.23 – 0.51 0.446 
Menarche <-0.01 <-0.01 -0.22 – 0.21 0.952 
BMI 0.31 0.29 0.04 – 0.05 0.025 
 
DISCUSSION 
Implantation process in endometrium is 
regulated with complex interaction between 
the embryo and endometrium. This dialogue 
is set to happen when a synchronization bet-
ween oocytes, endometrial maturation, 
followed by blastocyst orientation to endo-
metrial wall, along with apposition, adhesion, 
and invasion is accomplished. These simul-
taneous steps, from cellular adhesion, inva-
sion, until endometrial decasualization, are a 
part of implantation process (Raheem, 2018) 
During the majority of menstrual pha-
se, the endometrium basically denies embryo. 
Thus, physiological attempts are required to 
restore endometrium condition and enable 
implantation. In the early phase of menstrual 
cycle, the level of estrogen is increased, 
augmenting the proliferation of endometrial 
cells. After ovulation, the luteinized follicles 
secrete progesterone that matures endome-
trial cells in favor of implantation (Wu et al, 
2018). A receptive and fully functioned endo-
metrium is crucial for implantation. During 
menstrual cycle, endometrium undergoes 
biological and morphological changes, prepa-
ring the endometrium for embryonal inter-
action and successful implantation. After the 
biological alteration is adequate, the embryo 
will have the capacity to adhere, invade, and 
finally implanted in endometrium (Craciunas 
et al., 2019).  
Endometrial receptivity is morpho-
logically characterized by the presence of 
endometrial pinopodes – rounded nodules 
found on endometrial lining. Pinopodes are 
expressed in short period of time, appro-
ximately 2 days on menstrual cycle, also 
known as window of implantation. Blastocyst 
implantation is shown to occur in the peak of 
pinopode (Altmäe et al, 2017). 
Endometrial receptivity plays a key role 
in fertility. Any alteration in this factor will 
highly affect the success of assisted repro-
ductive technique (ART) and contribute to 
infertility in PCOS. Endometrium of woman 
with PCOS is considered to be a model of 
‘dysfunctional’ endometrium, with decreased 
expression of cytokines, immunomodulators, 
and the activity of steroid receptor; all of 
those lead to low fertility rate (Demiral et al, 
2015). In PCOS, the disruption of follicle 
maturation and prolonged anovulation will 
cause chronic progesterone deficiency, thus 
affecting the whole endometrial environ-
ment. Moreover, in PCOS, alterations of ex-
pressed steroid receptors and glucose trans-
porter 4 (GLUT 4) occurred due to proges-
terone resistance (Ruiz-Alonso et al, 2013). 
Women with PCOS may show irresponsive 
progesterone in vitro and altered production 
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of pro-implantation modulators including 
leptin (Altmäe and Aghajanova, 2015) 
Leptin expression is higher in PCOS 
group compared to control group, as shown 
in Table 3. Shows the Mann-whitney leptin 
expression test results in PCOS compared to 
normal. The mean leptin expression in SOPK 
was higher than the normal group of 59.16 ± 
49.34 and the normal group 6.0 ± 22.98 
which were statistically significantly different 
with p= 0.001. It can be concluded that leptin 
does have effect on endometrial receptivity. 
Thus, the use of leptin for endometrial recep-
tivity marker is encouraged. 
Leptin itself is included in many factors 
that contribute to blastocyst and endomet-
rium interaction, along with IGF-1, MUC-1, 
MMP-9, VEGF, and many other (Blesa et al., 
2014). Leptin has a dualism of effect in repro-
duction. Positively, leptin has the capacity to 
induce puberty in hypothalamus-pituitary 
axis by secreting estrogen. But when the 
expression is exaggerated, ovary response 
will be inhibited (Daghestani et al, 2018). 
Leptin expression is markedly reduced 
during the adhesion of conception product. 
During that time, because of the long dura-
tion, endometrium is exposed to progeste-
rone stimulation (Miravet-Valenciano et al., 
2015). After 8-10 days exposed to proges-
terone, the receptors in uterine lining will be 
down regulated, thus leads to the loss of its 
direct effect to endometrial cells. Leptin will 
be decreased and enabling receptive condi-
tion for conception products. The decrease of 
leptin is localized in particular receptor area 
(Méndez-López et al., 2017) 
Leptin has an anti-adhesive charac-
teristic that will lead to implantation failure if 
expressed excessively. The increase of leptin 
expression, as shown in PCOS, will disrupt 
embryo adhesion and increase the needs of 
progesterone receptors (Pérez-Pérezet al, 
2017). Leptin is also proven as a regulator of 
angiogenesis by augmenting the expression 
of vascular endothelial growth factor (VEGF) 
and its receptor, VEGF-R2; resulting in neo-
vascularization. The altered leptin level and 
sOB-R will disrupt angiogenesis and re-
modeling process during placenta formation, 
induce hyperactivity of angiogenic pathway, 
and ends with endothelial dysfunction. An 
observational study in 2014 by Perez et al 
stated that there is a correlation between 
excessive, deficient, and resistance of leptin 
with the abnormality of reproduction func-
tion (Pérez-Pérez et al., 2014) 
In Table 4 model 2, it was found that in 
obese women, leptin expression increased 
2.31-fold with p = 0.025 and 95% CI (0.04 - 
058). It is believed that body mass index is 
directly correlated with fat deposition. Leptin 
itself is synthetized from white adipose tissue 
(WAT) as a response of fat deposition in the 
body. Leptin will induce a feedback to hypo-
thalamus by suppressing appetite signal, 
such as AGRP, neuropeptide-Y (NP-Y), and 
galanin. In high adipose deposition, leptin is 
secreted in abundant amount, enabling the 
attachment of alpha-melanocyte stimulating 
hormone (α-MSH) to MCR-4 and suppress-
ing appetite. Meanwhile, when the fat deposit 
is low, leptin is secreted in low amount, enab-
ling AGRP to increase and attach to MCR-4, 
thus inducing appetite. In majority of obese 
individuals, however, the increase of leptin 
level is not followed by the use of energy or 
decrease in appetite (Sumadewi, 2017). In 
obese individuals, leptin is found in free-form 
as a result of sOB-R reduction; leptin func-
tion is also decreased. The resistance of leptin 
or inadequately functioned leptin is charac-
terized with hiperleptinemia (Rizk and Sha-
rif, 2015) 
It is also believed that hyperinsulinemia 
in PCOS also plays a part in anovulation, as a 
result of inhibited proliferation of granulose 
cells (Daghestani et al, 2018). Hyperinsuline-
mia and insulin resistance will induce the 
regulation of leptin mRNA in adipose, and 
Besar et al. / The Difference of Endometrial Leptin Expression in Woman 
www.theijmed.com  45 
conversely, leptin will inhibit the activation of 
gonadotropin in insulin-mediated steroid 
genesis (Rizk and Sharif, 2015). This condi-
tion will inhibit ovarian response and deliver 
negative effect to fertility. 
Leptin expression is significantly higher 
in PCOS and obese women. A high level of 
leptin will disrupt adhesion process, thus 
affecting endometrial receptivity. 
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